載入...
Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line
Pancreatic Cancer (PC) is a devastating lethal disease. Therefore, there is an urgent need to develop new intervention strategies. The mammalian Target of Rapamycin (mTOR) is a conserved kinase and master regulator of metabolism and cell growth. mTOR is dysregulated in chronic diseases including dia...
Na minha lista:
| 發表在: | Metabolomics (Los Angel) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315031/ https://ncbi.nlm.nih.gov/pubmed/28217402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2153-0769.1000183 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|